NM_017613.4:c.1282C>T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_017613.4(DONSON):c.1282C>T(p.Gln428*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,614,024 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_017613.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- microcephaly, short stature, and limb abnormalitiesInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251468 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461858Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727230 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74338 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.1282C>T (p.Q428*) alteration, located in exon 8 (coding exon 8) of the DONSON gene, consists of a C to T substitution at nucleotide position 1282. This changes the amino acid from a glutamine (Q) to a stop codon at amino acid position 428. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the T allele has an overall frequency of <0.01% (5/282858) total alleles studied. The highest observed frequency was 0.01% (2/30616) of South Asian alleles. This mutation has been reported in the compound heterozygous state in individuals with DONSON-related microcephalic dwarfism (Reynolds, 2017). Functional studies found that cells containing this mutation expressed less protein when compared to wild-type (Reynolds, 2017). Based on the available evidence, this alteration is classified as pathogenic. -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln428*) in the DONSON gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DONSON are known to be pathogenic (PMID: 28191891, 28630177). This variant is present in population databases (no rsID available, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with DONSON-related conditions (PMID: 28191891, 31785789, 33057194, 35982159). ClinVar contains an entry for this variant (Variation ID: 431419). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Microcephaly-micromelia syndrome;C4539873:Microcephaly, short stature, and limb abnormalities Pathogenic:1
- -
Microcephaly, short stature, and limb abnormalities Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at